Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
Abroad (travel likely)RecruitingPHASE2
Conditions
Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aflac Cancer & Blood Disorders Centers, Atlanta, Georgia, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Washington University School of Medicine, St Louis, Missouri, United States
Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Andrew Bukowinski, MD, MS) · Andrew.bukowinski2@chp.edu · (412) 692-8864Texas Children's Cancer Center, Houston, Texas, United States
Study leads
Kathryn Sutton, MD
Principal Investigator
Emory University